Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

NMDA‐receptor blockers but not NBQX, an AMPA‐receptor antagonist, inhibit spreading depression in the rat brain

NELLGÅRD, B. LU and WIELOCH, T. LU (1992) In Acta Physiologica Scandinavica 146(4). p.497-503
Abstract

The effect of different glutamate‐receptor antagonists on the induction of cortical spreading depression of Leao and of cortical anoxic membrane depolarization were investigated in the anaesthetized rat. Spreading depression (SD), elicited by mechanical stimulation of the cortical surface, was inhibited by the non‐competitive N‐methyl‐d‐aspartate (NMDA)‐receptor blocker, (±)‐5‐methyl‐10,11‐dihydro‐SH‐dibenzo(a, d)‐cyclo‐hepten‐5,10‐imine maleate (dizocilpine or MK‐801), (0. 30 μmol kg‐1 (0. 10 mg kg ‐1)), and the competitive NMDA‐receptor antagonists; cis‐4‐phosphonomethyl‐2‐piperidine carboxylate (CGS 19755), (3.36 μmol kg‐1 (0.75 mg kg‐1)), d‐(E)‐2‐amino‐4‐methyl‐5‐phosphono‐3‐pentenoic acid... (More)

The effect of different glutamate‐receptor antagonists on the induction of cortical spreading depression of Leao and of cortical anoxic membrane depolarization were investigated in the anaesthetized rat. Spreading depression (SD), elicited by mechanical stimulation of the cortical surface, was inhibited by the non‐competitive N‐methyl‐d‐aspartate (NMDA)‐receptor blocker, (±)‐5‐methyl‐10,11‐dihydro‐SH‐dibenzo(a, d)‐cyclo‐hepten‐5,10‐imine maleate (dizocilpine or MK‐801), (0. 30 μmol kg‐1 (0. 10 mg kg ‐1)), and the competitive NMDA‐receptor antagonists; cis‐4‐phosphonomethyl‐2‐piperidine carboxylate (CGS 19755), (3.36 μmol kg‐1 (0.75 mg kg‐1)), d‐(E)‐2‐amino‐4‐methyl‐5‐phosphono‐3‐pentenoic acid (CGP 40116), (1.20 μmol kg‐1 (0.25 mg kg‐1)) and its carboxylester CGP 43487, (6.30 μmol kg‐1 (1.50 mg kg‐1)). The α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepripriate (AMPA)‐receptor blocker, 2,3‐dihydroxy‐6‐nitro‐7‐sulfamoyl‐benzo(F) quinoxaline (NBQX), administered as an intravenous dose of 29.76 and 89.29 μmol kg‐1 (10 & 30 mg kg‐1), which is sufficient to block seizures and protect against ischaemic brain damage, did not inhibit spreading depression. None of the drugs utilized inhibited the anoxic membrane depolarization. The data demonstrate that NMDA‐receptor activation is essential for the initiation and propagation of spreading depression, while activation of AMPA‐receptors is not obligatory. The observed initiation and propagation of SD, during AMPA‐receptor blockade, suggest that activation of voltage‐operated ion channels may contribute to release the magnesium block of the NMDA‐receptor operated channel and to the initiation of SD.

(Less)
Please use this url to cite or link to this publication:
author
and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
glutamate, ischaemia, neuronal damage, seizures
in
Acta Physiologica Scandinavica
volume
146
issue
4
pages
7 pages
publisher
Wiley-Blackwell
external identifiers
  • pmid:1283483
  • scopus:0026685817
ISSN
0001-6772
DOI
10.1111/j.1748-1716.1992.tb09451.x
language
English
LU publication?
yes
id
c4b26925-5bc5-4750-ac74-8c1aacb5ed96
date added to LUP
2019-06-13 16:21:59
date last changed
2024-01-01 10:18:03
@article{c4b26925-5bc5-4750-ac74-8c1aacb5ed96,
  abstract     = {{<p>The effect of different glutamate‐receptor antagonists on the induction of cortical spreading depression of Leao and of cortical anoxic membrane depolarization were investigated in the anaesthetized rat. Spreading depression (SD), elicited by mechanical stimulation of the cortical surface, was inhibited by the non‐competitive N‐methyl‐d‐aspartate (NMDA)‐receptor blocker, (±)‐5‐methyl‐10,11‐dihydro‐SH‐dibenzo(a, d)‐cyclo‐hepten‐5,10‐imine maleate (dizocilpine or MK‐801), (0. 30 μmol kg<sup>‐1</sup> (0. 10 mg kg <sup>‐1</sup>)), and the competitive NMDA‐receptor antagonists; cis‐4‐phosphonomethyl‐2‐piperidine carboxylate (CGS 19755), (3.36 μmol kg<sup>‐1</sup> (0.75 mg kg<sup>‐1</sup>)), d‐(E)‐2‐amino‐4‐methyl‐5‐phosphono‐3‐pentenoic acid (CGP 40116), (1.20 μmol kg<sup>‐1</sup> (0.25 mg kg<sup>‐1</sup>)) and its carboxylester CGP 43487, (6.30 μmol kg<sup>‐1</sup> (1.50 mg kg<sup>‐1</sup>)). The α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepripriate (AMPA)‐receptor blocker, 2,3‐dihydroxy‐6‐nitro‐7‐sulfamoyl‐benzo(F) quinoxaline (NBQX), administered as an intravenous dose of 29.76 and 89.29 μmol kg<sup>‐1</sup> (10 &amp; 30 mg kg<sup>‐1</sup>), which is sufficient to block seizures and protect against ischaemic brain damage, did not inhibit spreading depression. None of the drugs utilized inhibited the anoxic membrane depolarization. The data demonstrate that NMDA‐receptor activation is essential for the initiation and propagation of spreading depression, while activation of AMPA‐receptors is not obligatory. The observed initiation and propagation of SD, during AMPA‐receptor blockade, suggest that activation of voltage‐operated ion channels may contribute to release the magnesium block of the NMDA‐receptor operated channel and to the initiation of SD.</p>}},
  author       = {{NELLGÅRD, B. and WIELOCH, T.}},
  issn         = {{0001-6772}},
  keywords     = {{glutamate; ischaemia; neuronal damage; seizures}},
  language     = {{eng}},
  month        = {{01}},
  number       = {{4}},
  pages        = {{497--503}},
  publisher    = {{Wiley-Blackwell}},
  series       = {{Acta Physiologica Scandinavica}},
  title        = {{NMDA‐receptor blockers but not NBQX, an AMPA‐receptor antagonist, inhibit spreading depression in the rat brain}},
  url          = {{http://dx.doi.org/10.1111/j.1748-1716.1992.tb09451.x}},
  doi          = {{10.1111/j.1748-1716.1992.tb09451.x}},
  volume       = {{146}},
  year         = {{1992}},
}